Eledon Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q2 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Eledon Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q2 2015 to Q3 2024.
  • Eledon Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2024 was 1.02K %, a 17.5% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 1.02K -217 -17.5% Sep 30, 2024
Q2 2024 1.49K +411 +38.1% Jun 30, 2024
Q1 2024 1.51K +353 +30.6% Mar 31, 2024
Q4 2023 1.41K -63.1 -4.29% Dec 31, 2023
Q3 2023 1.24K -580 -31.9% Sep 30, 2023
Q2 2023 1.08K -1.21K -52.9% Jun 30, 2023
Q1 2023 1.16K -1.44K -55.5% Mar 31, 2023
Q4 2022 1.47K -1.12K -43.2% Dec 31, 2022
Q3 2022 1.82K -1.34K -42.4% Sep 30, 2022
Q2 2022 2.29K -574 -20% Jun 30, 2022
Q1 2022 2.6K +77.4 +3.07% Mar 31, 2022
Q4 2021 2.59K +401 +18.4% Dec 31, 2021
Q3 2021 3.16K +1.74K +123% Sep 30, 2021
Q2 2021 2.86K +2.11K +280% Jun 30, 2021
Q1 2021 2.52K +1.78K +241% Mar 31, 2021
Q4 2020 2.19K +1.6K +274% Dec 31, 2020
Q3 2020 1.42K +862 +155% Sep 30, 2020
Q2 2020 754 Jun 30, 2020
Q1 2020 739 Mar 31, 2020
Q4 2019 585 Dec 31, 2019
Q3 2019 555 Sep 30, 2019
Q3 2017 617 -163 -20.9% Sep 30, 2017
Q2 2017 556 -402 -41.9% Jun 30, 2017
Q1 2017 534 -737 -58% Mar 31, 2017
Q4 2016 580 -892 -60.6% Dec 31, 2016
Q3 2016 780 -1.03K -56.9% Sep 30, 2016
Q2 2016 958 -1.03K -51.8% Jun 30, 2016
Q1 2016 1.27K Mar 31, 2016
Q4 2015 1.47K Dec 31, 2015
Q3 2015 1.81K Sep 30, 2015
Q2 2015 1.99K Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.